{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:05:04Z","timestamp":1698728704399},"reference-count":34,"publisher":"Baishideng Publishing Group Inc.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3748\/wjg.v10.i21.3165","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T01:23:36Z","timestamp":1445822616000},"page":"3165","source":"Crossref","is-referenced-by-count":7,"title":["Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicam"],"prefix":"10.3748","volume":"10","author":[{"given":"Yong-Qiu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh202"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.04.001"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/9.2.147"},{"key":"ref4","unstructured":"Hu Y, Zhao W, Qian X, Zhang L. Effects of oral administration of type II collagen on adjuvant arthritis in rats and its mechanisms. Chin Med J (Engl) 2003;116:284-287."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380811"},{"key":"ref6","unstructured":"Thompson SJ, Thompson HS, Harper N, Day MJ, Coad AJ, Elson CJ, Staines NA. Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 1993;79:152-157."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/ar1169"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1775::AID-ART313>3.0.CO;2-V"},{"key":"ref10","unstructured":"Higuchi K, Kweon MN, Fujihashi K, McGhee JR, Kiyono H. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis. J Rheumatol 2000;27:1038-1044."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-001-0052-z"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02167.x"},{"key":"ref13","unstructured":"Combe B, Flipo RM. [What treatments can reduce the digestive complications of NSAIDs]. Presse Med 2003;32:S33-S37."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.344"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2060::AID-ANR6>3.0.CO;2-L"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2003.09.032"},{"key":"ref17","unstructured":"Takeuchi K, Tanaka A, Ohno R, Yokota A. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. J Physiol Pharmacol 2003;54:165-182."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(98)00104-5"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(03)00051-1"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1081\/IAS-120013034"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200417772"},{"key":"ref22","unstructured":"Cazzola M, Antivalle M, Sarzi-Puttini P, Dell'Acqua D, Panni B, Caruso I. Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study. Clin Exp Rheumatol 2000;18:571-577."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01903.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1998.4615"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1999.0320"},{"key":"ref27","unstructured":"Albengres E, Urien S, Barre J, Nguyen P, Bree F, Jolliet P, Tillement JP, Tsai RS, Carrupt PA, Testa B. Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicity. Int J Tissue React 1993;15:125-134."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(98)00064-1"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh118"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427060-00005"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/10715760290032575"},{"key":"ref32","unstructured":"Song F, Whitacre CC. The role of the gut lymphoid tissue in induction of oral tolerance. Curr Opin Investig Drugs 2001;2:1382-1386."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1385\/IR:28:3:265"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/1568010023344850"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i21\/3165.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T10:46:35Z","timestamp":1511261195000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i21\/3165.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":34,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v10.i21.3165","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}